NCT07539168

Brief Summary

This retrospective cohort study evaluates clinical, surgical, and prosthetic factors associated with early and mid-term outcomes of immediate implant placement in the anterior maxilla. The primary objective is to identify predictors of implant survival and complications (e.g., infection, soft-tissue dehiscence, esthetic failure) within 12 months following placement. Secondary objectives include assessment of peri-implant marginal bone loss, prosthetic complications, and esthetic outcomes (pink esthetic score).

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
500

participants targeted

Target at P75+ for all trials

Timeline
3mo left

Started Jun 2026

Shorter than P25 for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 13, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

April 20, 2026

Completed
1 month until next milestone

Study Start

First participant enrolled

June 1, 2026

Expected
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2026

1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2026

Last Updated

April 22, 2026

Status Verified

April 1, 2026

Enrollment Period

2 months

First QC Date

April 13, 2026

Last Update Submit

April 17, 2026

Conditions

Keywords

Immediate implant, esthetics, anterior maxilla

Outcome Measures

Primary Outcomes (1)

  • Pink esthetic score

    3 years

Study Arms (1)

IIP in anterior maxilla

Immediate implant placement from canine to canine

Eligibility Criteria

Age21 Years - 55 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

All patients were treated with flapless immediate implants with no grafting procedures in the esthetic zone.

You may qualify if:

  • flapless immediately placed implants in esthetic zone with 3 years follow up CBCT,
  • presence of immediate postoperative CBCT,
  • initial intact thick gingival biotype with at least 2 mm band of keratinized tissue
  • thin intact labial bone plate (\< 1mm) extending 7 mm apically assessed by CBCT with good apical bone
  • patients who had provided an informed consent.

You may not qualify if:

  • patients with medical conditions that would compromise the surgical procedures, uncontrolled diabetes mellitus, taking IV bis-phosphonates for treatment of osteoporosis
  • patients with active infection related at the site of implant and patients with untreated active periodontal diseases.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
NETWORK
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Executive Director

Study Record Dates

First Submitted

April 13, 2026

First Posted

April 20, 2026

Study Start (Estimated)

June 1, 2026

Primary Completion (Estimated)

August 1, 2026

Study Completion (Estimated)

September 1, 2026

Last Updated

April 22, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share